Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Infusion of phagocytic macrophages overexpressing cpt1a ameliorates kidney fibrosis in the UUO model

  • Calle, Priscila
  • Játiva, Soraya
  • Torrico, Selene
  • Muñoz, Ángeles
  • García, Miriam R.
  • Sola, Anna
  • Serra, Dolors
  • Mera, Paula
  • Herrero, Laura
  • Hotter, Georgina
Phagocytosis is an inherent function of tissue macrophages for the removal of apoptotic cells and cellular debris during acute and chronic injury; however, the dynamics of this event during fibrosis development is unknown. We aim to prove that during the development of kidney fibrosis in the unilateral ureteral obstruction (UUO) model, there are some populations of macrophage with a reduced ability to phagocytose, and whether the infusion of a population of phagocytic macro-phages could reduce fibrosis in the murine model UUO. For this purpose, we have identified the macrophage populations during the development of fibrosis and have characterized their phagocytic ability and their expression of CPT1a. Furthermore, we have evaluated the therapeutic effect of macrophages overexpressing CPT1a with high phagocytic skills. We evidenced that the macro-phage population which exhibits high phagocytic ability (F4/80low-CD11b) in fibrotic animals de-creases during the progression of fibrosis while the macrophage population with lower phagocytic ability (F4/80high-CD11b) in fibrotic conditions, conversely, increases and CPT1a macrophage cell therapy with a strengthening phagocytic ability is associated with a therapeutic effect on kidney fibrosis. We have developed a therapeutic approach to reduce fibrosis in the UUO model by enrichment of the kidney resident macrophage population with a higher proportion of exogenous phagocytic macrophages overexpressing CPT1a., This research was funded by grants from the Ministerio de Economía y Competitividad, reference SAF2015–67770-R, awarded to G.H.; from the Fondo de Investigación Sanitaria (FIS), reference PI20/00900, awarded to G.H and the program Retos Colaboracion, reference: RTC2019- 007197-1, awarded G.H.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of Cell Therapies for Renal Disease and Regenerative Medicine

  • Torrico, Selene
  • Hotter, Georgina
  • Játiva, Soraya
The incidence of renal disease is gradually increasing worldwide, and this condition has become a major public health problem because it is a trigger for many other chronic diseases. Cell therapies using multipotent mesenchymal stromal cells, hematopoietic stem cells, macrophages, and other cell types have been used to induce regeneration and provide a cure for acute and chronic kidney disease in experimental models. This review describes the advances in cell therapy protocols applied to acute and chronic kidney injuries and the attempts to apply these treatments in a clinical setting., This research was funded by grants from Instituto de Salud Carlos III (ISCIII), reference PI20/00900, awarded to G.H., and the program Retos Colaboracion from the Ministerio de Economia y Competitividad, reference RTC2019-007197-1, awarded to G.H.